Open AccessTherapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan
Author(s) -
Koichiro Watanabe,
Shinji Fujimoto,
Tatsuro Marumoto,
T Kitagawa,
Kazuyuki Ishida,
Tadashi Nakajima,
Yoshiya Moriguchi,
Keita Fujikawa,
Takeshi Inoue
Publication year - 2022
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s340281
Subject(s) - anhedonia , vortioxetine , placebo , medicine , major depressive disorder , post hoc analysis , depression (economics) , sadness , antidepressant , psychiatry , alternative medicine , pathology , amygdala , anger , hippocampus , economics , macroeconomics , dopamine
Anhedonia in major depressive disorder may be resistant to first-line antidepressants. We examined the effect of vortioxetine, a multimodal antidepressant, on anhedonia-like symptoms in Japanese patients with major depressive disorder.